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We report the first diagnostic test for the identification of Staphylococcus pseudintermedius involving a simple
PCR-restriction fragment length polymorphism approach. The method allows discrimination of S. pseudinter-
medius from the closely related members of the Staphylococcus intermedius group and other important staph-
ylococcal pathogens of humans and dogs.
Until recently, Staphylococcus intermedius was considered
responsible for most cases of canine pyoderma, a major skin
disease of dogs (8). However, using a multilocus sequencing
approach, independent research groups have demonstrated
that isolates phenotypically identified as Staphylococcus inter-
medius consist of three distinct species, including S. interme-
dius, Staphylococcus pseudintermedius, and Staphylococcus del-
phini, which together represent the S. intermedius group (SIG)
(1a, 4). Importantly, it was discovered that S. pseudintermedius,
not S. intermedius, is the common canine pyoderma pathogen
and that S. delphini, isolated from a variety of different animals,
may be more clinically important than was previously thought
(1a, 4). The recently identified S. pseudintermedius (5) is occa-
sionally isolated from serious human infections, and the emer-
gence and spread of methicillin-resistant S. pseudintermedius
strains are major veterinary and public health issues (1a, 3, 4,
7, 11–13). Sasaki et al. could biochemically differentiate S.
intermedius from the other SIG species but was unable to
identify phenotypic markers to discriminate S. pseudinterme-
dius, the most clinically relevant species, from S. delphini (12),
and DNA sequencing is currently required to identify S. pseud-
intermedius (1a, 12). In order to address the need for a method
of discriminating clinical isolates of S. pseudintermedius, we
have developed a rapid, simple, and robust PCR-restriction
fragment length polymorphism (RFLP) approach which has
been validated independently in laboratories in separate coun-
tries.
Our previous population genetic study of SIG isolates ex-
amined sequence diversity at five gene loci among 104 isolates
(1a). In the current study, sequence analysis of one of the loci,
pta, which encodes the enzyme phosphoacetyltransferase, re-
vealed the presence of an MboI restriction site in all S. pseud-
intermedius isolates, which was absent in all S. intermedius and
S. delphini isolates examined. Based on this discovery we have
designed a simple, robust, and inexpensive PCR-RFLP diag-
nostic test for the identification of S. pseudintermedius. Staph-
ylococcal genomic DNA isolation was carried out as previously
described (1a). PCR amplification of a 320-bp fragment of the
pta gene was carried out in a 50-l volume with a 0.2 M
concentration of each oligonucleotide primer (pta_f1, AAA
GAC AAA CTT TCA GGT AA, and pta_r1, GCA TAA ACA
AGC ATT GTA CCG), a 0.2 mM concentration of the de-
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TABLE 1. Staphylococcal isolates previously identified to the





ED99 S. pseudintermedius Dog 
AV8001 S. pseudintermedius Dog 
95072195 S. pseudintermedius Dog 
94062394 S. pseudintermedius Dog 
N900260 S. pseudintermedius Human 
HT20030686 S. pseudintermedius Dog 
M72199 S. pseudintermedius Dog 
3279 (MRSP) S. pseudintermedius Dog 
3414 S. pseudintermedius Cat 
9075 S. pseudintermedius Dog 
690 S. pseudintermedius Cat 
8478 S. pseudintermedius Dog 
HH1 S. pseudintermedius Dog 
Can6 S. pseudintermedius Dog 
Can10 S. pseudintermedius Human 
BH47 S. pseudintermedius Dog 
AV8024 S. pseudintermedius Dog 
8016 S. pseudintermedius Dog 
LMG22219 S. pseudintermedius Cat 
LMG22220 S. pseudintermedius Horse 
ATCC 49171 S. delphini Dolphin 
HT20030680 S. delphini Camel 
9106 S. delphini Horse 
8485 S. delphini Horse 
AV8051 S. delphini Pigeon 
HT20030677 S. delphini Camel 
AV8047 S. delphini Pigeon 
HT20030676 S. delphini Camel 
HT20030674 S. delphini Camel 
8086 S. delphini Horse 
HT20030679 S. delphini Camel 
AV8061 S. intermedius Pigeon 
NCTC11048 S. intermedius Pigeon 
AV8063 S. intermedius Pigeon 
AV8063 S. intermedius Pigeon 
ATCC 43808 S. schleiferi subsp. schleiferi Human 
CCUG37248 S. schleiferi subsp. coagulans Dog 
Newman S. aureus Human 
N315 S. aureus Human 
a The isolates were previously identified by Bannoehr et al. (1). , present; ,
absent.
b S. pseudintermedius pta MboI restriction fragments were 107 bp and 213 bp,
and S. aureus pta MboI restriction fragments were 156 bp and 164 bp.
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oxynucleoside triphosphates, 1.5 mM MgCl2, 0.5 U Taq DNA
polymerase, and 50 ng DNA template, in a 1 reaction buffer.
Thermocycling conditions included a 95°C incubation for 2 min
followed by 30 cycles of 95°C for 1 min, 53°C for 1 min, and
72°C for 1 min, with a final incubation of 72°C for 7 min.
Twenty-five-microliter samples of the PCR mixtures were in-
cubated with 5 U of MboI and 5 l of 5 digestion buffer for
2 h, and the digestion products were resolved in 2% (wt/vol)
agarose by electrophoresis. We investigated the efficacy of the
technique by the analysis of well-characterized isolates of S.
pseudintermedius, S. intermedius, and S. delphini that repre-
sented the breadth of diversity identified within the SIG and
that included the type strains (1). In addition, representative
isolates of Staphylococcus aureus, Staphylococcus schleiferi
subsp. coagulans, and Staphylococcus schleiferi subsp. schleiferi,
which are associated with human and canine infections, were
included (Table 1). A pta PCR product of 320 bp was success-
fully amplified from all strains examined. S. pseudintermedius
PCR products all contained a single MboI site, resulting in two
restriction fragments of 213 bp and 107 bp, respectively (Fig.
1). In contrast, SIG species S. delphini and S. intermedius and
the S. schleiferi strains did not contain an MboI restriction site
(Fig. 1). S. aureus isolates contained a unique MboI site, re-
sulting in restriction fragments of 156 bp and 164 bp that
appeared as a single band after agarose electrophoresis; this
band was readily distinguishable from the S. pseudintermedius
restriction fragment profile (Fig. 1). Our data indicate that the
PCR-RFLP assay is an effective approach to S. pseudinterme-
dius identification, allowing discrimination from the other SIG
species and important staphylococcal pathogens of dogs (6, 9).
In order to test the reproducibility of the method, independent
investigators applied the approach in a diagnostic laboratory in
Italy to a panel of 112 coagulase-positive staphylococcal field
isolates which had been isolated from dogs, cats, cows, horses,
wild foxes, and a captive bear and identified as either SIG or S.
aureus (2). Of the 86 isolates from dogs, 85 were identified as
S. pseudintermedius by the PCR-RFLP approach, consistent
with our previous findings that S. pseudintermedius is a com-
mon commensal of dogs and the major canine pyoderma
pathogen. The remaining isolate resulted in a pta restriction
profile which indicated an S. aureus identity. All but 1 of the 14
isolates from cats, all 3 isolates from wild foxes, and the single
isolate from a captive bear were identified as S. pseudinterme-
dius. The remaining isolate of feline origin had an S. aureus-
specific restriction profile. A previous study reported the iso-
lation of S. intermedius from different species of the canoidea,
including bears and foxes (1). Our data suggest that S. pseud-
intermedius may be the most common SIG species associated
with these animals. All five isolates from equid genital swabs
did not contain a pta MboI site, consistent with our previous
findings that S. delphini is the SIG species commonly identified
among horses, and three isolates from equine respiratory tracts
and a skin lesion were identified as S. aureus. Finally, of the
seven isolates from cows, two were S. pseudintermedius and five
were identified as S. aureus. To our knowledge, this represents
the first reported identification of S. pseudintermedius in asso-
ciation with cows.
Until now, the lack of unique phenotypic markers for S.
pseudintermedius in comparison to the other SIG members has
precluded its identification without DNA sequencing. Impor-
tantly, due to the presence of common phenotypic markers, S.
pseudintermedius is occasionally misidentified as S. aureus in
human clinical diagnostic laboratories (10). The simple PCR-
RFLP approach presented here represents the first reported
diagnostic method which is effective for the identification of S.
pseudintermedius and for its discrimination from other SIG
species and several other important staphylococcal pathogens.
As such, the method should prove extremely useful in routine
veterinary diagnostic and clinical microbiology laboratories.
We thank Fabiola Feltrin, Angela Ianzano, and Cinzia Onorati for
technical support.
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